20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T22644 | C2 Ceramide | Ceramide | Others |
A potent modulator of cell proliferation and differentiation. | |||
T37562 | C16 Ceramide | N-acylsphingosine,C16 Ceramide (d18:1/16:0),Palmitoyl Ceramide,N-Palmitoylsphingosine | p53 |
C16 Ceramide (Palmitoyl Ceramide) is a naturally occurring small molecule that activates p53 by directly and selectively binding to it. | |||
T37436 | C12-Ceramide | N-Laurylsphingosine,C12 Ceramide (d18:1/12:0),N-Lauroyl-D-erythro-sphingosine | |
C12-Ceramide (C12 Ceramide (d18:1/12:0)), a ceramide present in the protective membranes surrounding umbilical cord blood vessels in infants born to women with pre-eclampsia, can be used to assess the level of ASM activi... | |||
T37563 | C22 Ceramide (d18:1/22:0) | Cer(d18:1/22:0),C22 Ceramide,Ceramide (d18:1/22:0) | |
C22 Ceramide (d18:1/22:0) (C22 Ceramide), a long-chain ceramide containing behenic acid, is an endogenous bioactive sphingolipid.C22-Ceramide specifically inhibits MCSR and reduces C16 ceramide channel formation in isola... | |||
T61884 | C6 Ceramide | N-hexanoylsphingosine,N-(hexanoyl)sphing-4-enine | Apoptosis |
C6 Ceramide (N-hexanoylsphingosine) is an activator of the ceramide pathway that arrests cells in the G0/G1 phase by activating ERK. It can act in a variety of cancer cell lines. | |||
T35803 | C14 Ceramide (d18:1/14:0) | Cer(d18:1/14:0),N-Myristoyl-D-sphingosine | |
C14 Ceramide (d18:1/14:0) is an endogenous ceramide produced by ceramide synthetase 6, which can be used for Parkinson's research. | |||
T78461 | C6 NBD Ceramide | Nbd-ceramide | |
C6 NBD Ceramide is a cell-permeable Golgi fluorescent probe (Ex=466 nm, Em=536 nm), a neuraminidic acid with a green fluorescent tag that can recognize Golgi apparatus in live and fixed cells, observing morphological cha... | |||
T36140 | BODIPY-C12 Ceramide (d18:1/12:0) | BODIPY-C12 Ceramide (d18:1/12:0) | |
BODIPY-C12 Ceramide (B12Cer) is a fluorescently-tagged form of C12 ceramide, with excitation/emission maxima at 505/540 nm, respectively. It is a fluorescently-labeled sphingolipid and has been utilized for quantifying a... | |||
T35873 | C19 Ceramide (d18:1/19:0) | C19 Ceramide (d18:1/19:0) | |
C19 Ceramide is a naturally occurring ceramide that has been found in J. juncea extracts as well as rat brain and mouse heart.[1],[2],[3] It is elevated in adult and decreased in juvenile whole rat brain extracts by 114 ... | |||
T36322 | C8 D-threo Ceramide (d18:1/8:0) | C8 D-threo Ceramide (d18:1/8:0) | |
C8 D-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides. It is cytotoxic to U937 cells (IC50 = 17 μM) and induces nuclear DNA fragmentation 5- to 6-fold more potently th... | |||
T36230 | C2 Ceramide (d14:1/2:0) | C2 Ceramide (d14:1/2:0) | |
C2 Ceramide (d14:1/2:0) is a bioactive sphingolipid. Dietary administration of C2 ceramide (d14:1/2:0) (100 μM) induces lipotoxic cardiomyopathy via increasing diastolic and systolic diameter as well as reducing fraction... | |||
T36188 | Ceramide Phosphoethanolamines (bovine) | ||
Ceramide phosphoethanolamine (CPE) is an analog of sphingomyelin that contains ethanolamine rather than choline as the head group. It is the principal membrane phospholipid in invertebrates such as Drosophila, which lack... | |||
T36321 | C6 Urea Ceramide | ||
C6 urea ceramide is an inhibitor of neutral ceramidase.1 It increases total ceramide levels in wild-type mouse embryonic fibroblasts (MEFs) and in HT-29 colon cancer cells but not in MEFs lacking neutral ceramidase. It i... | |||
T37564 | C4 Ceramide (d18:1/4:0) | C4 Ceramide (d18:1/4:0),Cer(d18:1/4:0) | |
C4 Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides. [1] [2] [3] It inhibits IL-4 production by 16% in EL4 T cells stimulated with phorbol 12-myristate 13-acetate when used... | |||
T37456 | C18 L-erythro Ceramide (d18:1/18:0) | C18 L-erythro Ceramide (d18:1/18:0) | |
C18 L-erythro Ceramide is a naturally occurring ceramide and stereoisomer of C18 ceramide . It inhibits rat brain mitochondrial ceramidase (mt-CDase) with an IC50 value of 0.11 mol% (8.8 μM). | |||
T36320 | C6 L-threo Ceramide (d18:1/6:0) | C6 L-threo Ceramide (d18:1/6:0) | |
C6 L-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides., C6 L-threo Ceramide is cytotoxic to U937 cells in vitro (IC50 = 18 μM). It is metabolically inactive and, unlik... | |||
T36324 | C8 L-threo Ceramide (d18:1/8:0) | C8 L-threo Ceramide (d18:1/8:0) | |
C8 L-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides. It is cytotoxic to U937 cells (IC50 = 10 μM) and, like C8 D-threo ceramide , induces nuclear DNA fragmentation 5... | |||
T35927 | C2 L-threo Ceramide (d18:1/2:0) | C2 L-threo Ceramide (d18:1/2:0) | |
C2 L-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides. It stimulates cholesterol efflux in CHO cells expressing the human ABCA1 receptor when used at a concentration o... | |||
T37457 | C18 L-threo Ceramide (d18:1/18:0) | C18 L-threo Ceramide (d18:1/18:0) | |
C18 L-threo Ceramide is a synthetic ceramide and stereoisomer of C18 ceramide that has been used for structural characterization of natural sphingolipids. It inhibits rat brain mitochondrial ceramidase (mt-CDase) with an... | |||
T36319 | C6 L-erythro Ceramide (d18:1/6:0) | C6 L-erythro Ceramide (d18:1/6:0) | |
C6 L-erythro Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides. It is metabolized by ceramide glucosyltransferase to form C6 L-erythro glucosylceramide. C6 L-erythro Ceramide... |